Spyre Takes Aim At Roche And J&J In Inflammatory Diseases

 
• By Andrew McConaghie
  
Spyres' CEO said it aims to 'stand on the shoulders' of J&J's leadership in inflammatory bowel disease. (Shutterstock)

More from Clinical Trials

More from Therapy Areas